GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/24/2023 | 1.39% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
| 07/21/2023 | 1.39% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
| 05/15/2023 | 14.07% | Goldman Sachs | $33 → $9 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/24/2023 | 1.39% | 高盛 | $9→$8 | 維護 | 中性 |
| 07/21/2023 | 1.39% | 高盛 | $9→$8 | 維護 | 中性 |
| 2023年05月15日 | 14.07% | 高盛 | $33→$9 | 維護 | 中性 |
What is the target price for GeneDx Hldgs (WGS)?
GeneDx Hldgs(WGS)的目標價是多少？
The latest price target for GeneDx Hldgs (NASDAQ: WGS) was reported by Goldman Sachs on July 24, 2023. The analyst firm set a price target for $8.00 expecting WGS to rise to within 12 months (a possible 1.39% upside). 3 analyst firms have reported ratings in the last year.
高盛於2023年7月24日報道了GeneDx Hldgs(納斯達克：WGS)的最新目標價。這家分析公司將目標價定為8.00美元，預計WGS將在12個月內上漲至1.39%(可能上漲1.39%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for GeneDx Hldgs (WGS)?
GeneDx Hldgs(WGS)的最新分析師評級是多少？
The latest analyst rating for GeneDx Hldgs (NASDAQ: WGS) was provided by Goldman Sachs, and GeneDx Hldgs maintained their neutral rating.
高盛提供對GeneDx Hldgs(納斯達克代碼：WGS)的最新分析師評級，GeneDx Hldgs維持中性評級。
When is the next analyst rating going to be posted or updated for GeneDx Hldgs (WGS)?
GeneDx Hldgs(WGS)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GeneDx Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GeneDx Hldgs was filed on July 24, 2023 so you should expect the next rating to be made available sometime around July 24, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公開財務報表，與GeneDx Hldgs的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。GeneDx Hldgs的上一次評級是在2023年7月24日提交的，所以你應該預計下一次評級將在2024年7月24日左右的某個時候提供。
Is the Analyst Rating GeneDx Hldgs (WGS) correct?
分析師對GeneDx Hldgs的評級正確嗎？
While ratings are subjective and will change, the latest GeneDx Hldgs (WGS) rating was a maintained with a price target of $9.00 to $8.00. The current price GeneDx Hldgs (WGS) is trading at is $7.89, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的GeneDx Hldgs(WGS)評級維持不變，目標價在9.00美元至8.00美元之間。GeneDx Hldgs目前的交易價格為7.89美元，超出了分析師的預測區間。